Contact information of Springer
Corrections
All material on this site has been provided by the respective publishers and authors. You can help
correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:hecrev. See general information about how to correct material in RePEc.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com/economics/journal/13561 .
Content
December 2026, Volume 16, Issue 1
- 1-2 Correction: Societal cost-of-illness analysis of self-injection of biologics for patients with rheumatoid arthritis in Japan using claims, surveys, and national statistics
by Kazuhiko Takahata & Eiichi Tanaka & Ryoko Sakai & Manabu Akazawa
- 1-3 Comment on: effects of emergency department length of stay on inpatient utilization and mortality
by Ching-Yi Chen & Shih-Fen Tseng & Yung-Shuo Kao & Raymond Nien-Chen Kuo
- 1-4 Procurement in German office based ambulatory physician practices: system specific challenges and evidence based management strategies
by Matthias B. Stope
- 1-7 Overview of the Japanese Rapid Introduction Premium as a drug pricing framework to enhance patient access to innovative drugs
by Kento Takamura & Gai Jinnai & Yuki Niwa & Masuo Kondoh
- 1-8 Factors associated with breast cancer screening among insured and uninsured women in Tanzania: an analysis of the Tanzania demographic and health survey 2022
by Amani Anaeli & Pankras Luoga & Tumaini Nyamhanga & Malale Tungu
- 1-8 Can AI write your code? A case study of chatgpt’s statistical coding capabilities for quantitative research
by Debra Winberg & Ethan Tsai & Tiange Tang & Dennis Xuan & Nicolas Marchi & Lizheng Shi
- 1-9 All-in-one spinal cord stimulation and its economic impact
by José Emilio LLopis Calatayud & Mónica Ocón & Pablo Evaristo Bretos-Azcona & Desire Rodriguez Bezos
- 1-9 Systematic review of health economic evaluation of robot-assisted hip and knee arthroplasty
by Yajing Gao & Yi Yang & Zhuofu Li & Bai Zang & Chengfengyi Yang & Feifei Zhou & Qiaoqin Wan
- 1-9 An economic analysis of the impact of education on health behaviours and health outcomes in South Africa: a case of Amathole District Municipality and Buffalo City Metropolitan Municipality
by Besuthu Hlafa & Asrat Tsegaye & Matt Dickson & Dumisani Macdonald Hompashe
- 1-9 Economics of diagnosis of disabilities among adults and children: evidence from Russia
by Artyom Jelnov & Maria Yuzefov
- 1-9 Cost-utility analysis of eptinezumab for migraine prevention in Taiwan
by Cheng-Shen Chan & Tzu-Yao Huang & Wei-Hsuan Tseng & Tsung-Kun Lin & Fu-Chi Yang & Yi Liu & Yuan-Zhen Ruan & Ping-Hsuan Hsieh
- 1-9 Value of information analyses for advanced cell therapies: a systematic review
by Alexander Heaps & Sean P. Gavan
- 1-9 Stated preferences in the Iranian health system: a systematic review of discrete choice experiments and conjoint analysis
by Lucie Sabin & Mohammad Hajizadeh & Hassan Haghparast-Bidgoli & Ali Kiadaliri
- 1-10 The economic burden of diabetes-related visual impairment and blindness in Saudi Arabia
by Gihan Hamdy Elsisi & Abdullah Alhumaidan & Abdulrahman Alturaiki & Hana Abdul Kareem & Nada Abu-Shraie & Ramzi Al Judaibi & Saleh Alshehri
- 1-10 Beyond average costs: large-scale evidence on DRG payment reform and the distribution of standardized inpatient spending in China
by Zhuang Cao & Yifan Yao & Bin Cui & Jian Wang & Changli Jia
- 1-10 Has volume-based procurement reduced household catastrophic health expenditure in rural patients with chronic disease?—Evidence from CHARLS 2018 and 2020 in China
by Shaoliang Tang & Shuo Sun & Yunjie Feng & Yuke Xu & Yiwei Shi
- 1-10 Economic burden of blindness and moderate to severe vision impairment in Slovenia
by Nina Vidic Krhlikar & Dalibor Gavrić & Mojca Globočnik Petrovič & Karmen Janša & Nataša Vidović Valentinčič & Petra Došenović Bonča
- 1-10 Nasogastric vs. nasojejunal feeding in stroke patients under a DRG payment system: balancing clinical benefits and economic costs
by Jing Mei & Jiyu Chen & Fei Xie & Yang Xu & Jia Li & Yi He & Bin Mei
- 1-10 Formal and informal financial inclusion and its impact on health: empirical evidence from South Africa
by Lwando Mjacu & Vikela Liso Sithole & Palesa Makhetha-Kosi
- 1-10 Cost analysis of financial, productivity, and informal care burdens in families raising children with congenital anomalies
by Evelina Marija Vaitėnienė & Audronė Jakaitienė & Liubovė Murauskienė & Algirdas Utkus
- 1-11 Cost-benefit potential of sperm function testing to the treatment pathway for unexplained infertility: a modelling study from the UK NHS perspective
by Shen Chuen Khaw & Jonathan SY Lee & Huang Lin Khaw & Christopher LR Barratt & Sarah Martins da Silva
- 1-11 The economic burden of maternal mortality: a scoping review
by Angela Nana Esi Ackon & Alberta Ama Atta Ackon & Thomas Abugbilla Atugba & Livingstone Asem
- 1-11 Health-related quality of life in COVID-19 in the United Kingdom: a vignette study
by Dionysios Ntais & Viola Ntim & Samantha Barton & Alex Porteous & Alvin Ng & Jennifer Page & Hardik Goswami & Victoria Coles & Amy Puenpatom
- 1-11 Evaluation of the efficiency of county-level medical and health services under the background of county medical community policy: a case study of Sanming, China
by Lina Zhao & Tangsiwei Xin & Xiaoran Wang & Limeng Zhu & Yafang Li & Hong Tan & Zongjiu Zhang
- 1-11 Latent profiles of health insurance literacy, numeracy and supplementary voluntary health insurance enrollment
by Tong Liu & Lei Liu & Lizheng Xu & Chaofan Li
- 1-11 Economic evaluation of automated scalp cooling systems for breast cancer patients in Spain
by Hernández-Yumar Aránzazu & García-Pérez Lidia & González-Pacheco Himar & de Armas-Castellano Aythami & Antón Torres Antonio & Martín Jiménez Miguel & Rueda-Domínguez Antonio & Serrano-Aguilar Pedro & Trujillo-Martín María del Mar
- 1-11 Thailand’s health financing resilience during COVID-19: leveraging universal health coverage to tackle the pandemic
by Aungsumalee Pholpark & Sikarn Issarachaiyos & Ilada Sooknark & Orawan Prasitsiriphon & Praewa Kulatnam & Papada Ranron & Sirithorn Khositchaiwat & Piya Hanvoravongchai & Yot Teerawattananon
- 1-11 Cost-utility analysis of three PD-1 inhibitors combined with chemotherapy in the first-line treatment of locally advanced or metastatic esophageal squamous carcinoma in China
by Li Liao & Jing Gong
- 1-11 The cost-effectiveness of telestroke in the treatment of acute ischemic stroke in China
by Lifeng Huang & Xuezhu Li & Hanting Liu & Wensu Zhou & Hui Zhang
- 1-11 The Spanish transplantation model as a benchmark: clinical, societal, and economic impact of liver transplants in Spain (1984–2024)
by Edson Plasencia Sánchez & Concepción Gómez Gavara & Glòria Merino Pinto & Roger Sabater Mezquita & Itxarone Bilbao & Gerardo Blanco-Fernández & Gloria de la Rosa & Gemma Piella
- 1-11 Cost of chemotherapy-related care for breast cancer care: evidence and implications from a provider perspective at a public tertiary hospital in South Africa
by Ck Oladayo & M. Sibanda & L. Makhele & M. Matlala
- 1-11 Productivity costs of type 2 diabetes with or without co-occurring substance use disorder and depression
by Olli Kurkela & Saara Metso & Leena Forma & Kimmo Suokas & Pekka Rissanen & Jaakko Nevalainen
- 1-11 Policy options for controlling rising hospital prices and their outcomes: a framework-based analysis
by Mohammad Ali Rezaei & Hamid Pourasghari & Ali Akbari Sari & Aziz Rezapour
- 1-12 Point-of-care core needle biopsy pathway for early diagnosis of lymph node masses: comparative costing of a scalable pathway
by David Richardson & Waarisa Fareed-Brey & Katherine Antel & Karryn Brown & Jenna Bailey & Estelle Verburgh & Lucy Cunnama
- 1-12 Cost-effectiveness of zanubrutinib versus ibrutinib in the first-line treatment for patients with chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) in China
by Ying Liu & Wei Li & Xiaoxia Wei & Haijing Guan & Sheng Han
- 1-12 A systematic review on indirect costs related to loss of productivity after stroke
by Adrián Martín-Gutiérrez & Luis Leal-Vega & María Begoña Coco-Martín & Verónica Olmedo-Vega & Juan F. Arenillas-Lara
- 1-12 Cost-utility of first-line dostarlimab plus carboplatin-paclitaxel compared with placebo for patients with pA/rEC: a partitioned survival analysis
by Ziyad S. Almalki & Saba S. Albanna & Yahia A. Hadadi & Ahmed M. Alshehri & Kamar Z. Jamal & Saja H. Almazrou & Jameilh A. Alsamiri & Abdulrahman A. Alsuhibani & Abdullah A. Alalwan & Ahmad A. Alamer & Nehad J. Ahmed & Abeer A. Shhada & Ghuafran A. Alnajem
- 1-12 Community-based care services and outpatient utilization among older adults: evidence from urban China
by Shuaizhen Chen & Fengyi Sun & Zhan Zhao & Jialong Tan
- 1-12 The impact of annual price revision based on external reference pricing on medicines between 2012 and 2023
by José Zorro Mendes & Inês Teixeira & José Pedro Guerreiro & Klára Dimitrovová & Frederico Silva Leal & António Teixeira Rodrigues
- 1-12 Assessing the scope and reporting quality of published health economic evaluation studies in Jordan: a systematic literature review
by Lama Sheikha & Rasha M. Arabyat
- 1-12 Preferences for hospital in the home for COVID-19: a discrete choice experiment study
by Mohammad Ehsanikia & Vajihe Ramezani-Doroh & Deborah Street & Leili Tapak & Yadolah Hamidi
- 1-12 Pooled survival and cost-effectiveness analysis of immune checkpoint inhibitors-based for metastatic non-small-cell lung cancer with PD-L1 lower than 1%
by Kun Liu & Youwen Zhu & Hong Zhu & Manting Zeng
- 1-12 Economic evaluation of direct oral anticoagulants (DOACs) for venous thromboembolism with different etiologies: a systematic review
by Fereshte Karimi & Soheila Rajaie & Samad Azari & Mohammad Saeid Abbaszadeh & Zeinab Karimi
- 1-12 Efficiency of health systems in developing countries: the case of West African countries
by Kossivi Akoetey & Anne Viallefont
- 1-12 Longitudinal trends and future projections of injury-related economic burden among middle-aged and older adults in China: analysis of CHARLS data 2011–2018
by Shaobo Zeng & Chen Liang & Shuanglong Yuan & Shuang Han & Caihong Li & Abulikemu Aili & Yaying Zhang & Guliziba Kuerbanjiang & Mingqin Cao
- 1-12 Health economic analysis of organizational models for breast cancer surgery: a bottom-up micro-costing and cost-minimization approach
by Johan Eriksson & Kaspar Walter Meili & Lena Lindholm & Micael Appelblad & Malin Sund
- 1-12 Economic burden and cost of non-adherence in type 2 diabetes: a systematic review of middle- and high-income countries
by Piedad Gómez-Torres & Isabel Rosario Blázquez-Ornat & María Luisa Lozano Del Hoyo & Ma. Esther Samaniego-Díaz de Corcuera & Emilia Ferrer-López & Enrique Ramón-Arbués & Sofía Pilar Pérez-Calahorra & Manuel Gómez-Barrera & Maria Teresa Fernández-Rodrigo
- 1-12 Economic evaluation of national immunization program vaccines in China: a systematic review
by Jiannan Sun & Xu Jin & Haofei Li & Lan Zhou & Ling Jie Cheng & Runhong Li & Jiaxuan Shi & Yiyin Cao & Jinmei Li & Xiuzhi Cai & Tiemin Zhai & Weidong Huang
- 1-12 Comparative cost-effectiveness analysis of different treatment strategies for distal radius fracture
by Haiyu Xu & Youhui Lin & Zihao Liu & Liying Zhao & Wei Cheng
- 1-13 Reducing breast cancer recurrences with CDK4/6 inhibitor treatment of HR-positive, HER2-negative early stage breast cancer from a societal perspective
by Stephanie Reitzinger & Thomas Czypionka & Gabriel Rinnerthaler
- 1-13 Cost-effectiveness of using Intravenous Ferric Carboxymaltose compared to Intravenous Iron Sucrose for treatment of iron deficiency anemia in pregnancy
by Beena Joshi & Tejal Varekar & Revathy R & Kiran Sangwan & Deepti Tandon & Ragini Kulkarni & Shahina Begum
- 1-13 Economic and health-related quality of life impacts of posttraumatic stress disorder: a systematic review
by Tran Hoang Tien & Tran Thu Ngan & Mai Xuan Thu & Meenakshi Sharma & Grainne Crealey & Ciaran O’Neill
- 1-13 Economic evidence of alternative formulations and routes of administration for identical active pharmaceutical ingredient: a systematic review
by Hanqiao Shao & Yunong Jiang & Mingye Zhao & Wenxi Tang
- 1-13 Health economics evaluation of artificial intelligence in the field of oncology: a scoping review
by Hein Minn Tun & Hanif Abdul Rahman & Lin Naing & Owais Ahmed Malik
- 1-13 The feasibility of social impact bonds in financing tertiary health care quality: qualitative stakeholders’ perspectives in Kenya
by Ezekiel Karino & James Ndegwa & Vincent Were
- 1-13 A systematic review of modeling approaches to evaluate diagnostics programs for stable coronary heart disease: suggestions for future health economic models
by Wei Li & Haonan Li & Shuhua Tan & Mengtian Cai & Sheng Han & Yingyao Chen
- 1-13 Smokers’ willingness to pay for smoking cessation services and its determinants: evidence from China
by Jia Li & Yixin Zhao & Kexin Peng & Jiushun Zhou & Lian Yang
- 1-13 Factors influencing the reimbursement decisions of cancer drugs in Spanish National Health System
by Pelayo Nieto-Gómez & Celia Castaño-Amores & Antonio José García-Ruiz & Juan Oliva-Moreno
- 1-13 Medical care cost dynamics during COVID-19 pandemic: financial implications for Japanese health insurance system
by Yuji Hiramatsu & Yuji Frui & Hiroo Ide
- 1-13 Presenting a pragmatic model for evaluating the economic performance of hospitals in Iran based on multi-criteria decision-making
by Jalal Saeidpour & Ehsan Teymourzadeh & Parisa Mehdizadeh & Mohammad Amiri-Ara
- 1-13 The economic burden of COVID-19 undervaccination: costs of hospitalisation, ICU admission, and death in Scotland
by Steven Kerr & Joan E. Madia & Catia Nicodemo & Aziz Sheikh
- 1-13 Generative AI in healthcare: redefining clinical practice through digital transformation
by Jackie Zhanbiao Li & Xin Li & Qifeng Wu & Qianhui Ting & Yingqian Lao
- 1-14 Developing shortcut algorithms for value-based pricing of pharmaceuticals
by Afschin Gandjour
- 1-14 The complex price setting and reimbursement of non-industrial advanced therapy medicinal products
by Zuzana Špacírová & Juan Carlos Rejon-Parrilla & Jaime Espín
- 1-14 Cost-effectiveness of AI-enhanced breast cancer screening in Iran: a microsimulation study
by Sajjad Dorri Kafrani & Rajabali Daroudi & Morteza Mohammadzadeh
- 1-14 Cost–benefit analysis of pre-entry tuberculosis screening for incoming migrants to Japan: a focus on Nepalese migrants
by Yoko Iwaki & Takayuki Hayashi & Shuhei Nomura & Shoko Shimamura & Rohita Gauchan & Michael C. Huang
- 1-14 Costs and cost-effectiveness of type 2 diabetes management in Sub-Saharan Africa: a systematic review
by Assegid Hellebo & Andre P. Kengne & Olufunke A. Alaba
- 1-14 Prospective payment system transformation (2000–2024): temporal trends, payment architecture, and cross-national variation
by Anahita Behzadi & Zohreh Bagherinezhad & Maliheh Ghobadi
- 1-14 Effects of housing demolition on health and medical utilization: evidence from China
by Di Yang & Yubraj Acharya
- 1-14 Beyond spending: nonlinear impacts of health financing and out-of-pocket costs on mortality in Africa
by Denis Folitse & Christopher Odoom & Alexander Boateng & Luis Alberiko Gil-Alana
- 1-14 Preferences towards digital health technologies: a scoping review
by Aimée Kingsada & Silvana Briones-Piedrafita & Thomas Rapp & Jonathan Sicsic
- 1-15 Beyond seed funding: why Nigerian digital health startups struggle to grow
by Ubalaeze Solomon Elechi & Chibuzo Okechukwu Onah & Mohamed Albert Tarawallie & Ironuru Ifeanyi
- 1-15 Sustainable financing in Iran’s health system: a policy analysis of agenda-setting through Kingdon’s multiple streams framework
by Anahita Behzadi & Mohsen Barooni & Amirhossein Fatahpour
- 1-15 Residents’ preferences for inclusive commercial supplementary medical insurance: a discrete choice experiment
by Yeyi Feng & Gaojie Li & Shumin Wu & Qingran Sun & Xiaoyu Xi & Ennan Wang
- 1-15 Who wants to pay more taxes for better long-term care services: evidence from OECD surveys
by Sylvain Botteron & Christophe Courbage & Joël Wagner
- 1-15 Cost-effectiveness of maternal and neonatal health interventions in Ethiopia: a systematic review and meta-analysis
by Akalu Duguma Sima & Endale Tamiru Burayu & Zelalem Banjaw Zegeye
- 1-15 Burden or benefit? Unveiling the impact of out-of-pocket health expenditures in Somalia’s healthcare system
by Khalid Mohamed Mohamud & Said Yusuf Warei & Ali Hajji Adam Abubakr
- 1-15 The global economic burden of schizophrenia: an umbrella review of systematic reviews and meta-analyses with reconstructed primary-study cost data
by Attila Imre & Ágota Mészáros & Bertalan Németh & Balázs Nagy & Judit Józwiak-Hagymásy & Giacomo Cecere & Philipp Homan & Iris E. C. Sommer & Balázs Babarczy
- 1-15 Paying for hospital care in seven central and Eastern European countries – a comparative analysis
by Katarzyna Dubas-Jakóbczyk & Krisztina Davidovics & Antoniya Dimova & Triin Habicht & Pavel Hroboň & Laszlo Imre & Kaija Kasekamp & Mincho Minev & Liubove Murauskienė & Martin Smatana & Gyoergy Rethazi & Angelika Szalayova & Artur Szetela & Lenka Šlegerová & Roman Topór-Mądry
- 1-15 Assessing the impact of government healthcare expenditure and life expectancy on economic growth in Saudi Arabia: an econometric time-series study (2000–2023)
by Razan Alghannam & Abeer Alharbi
- 1-15 A methodological analysis of systematic reviews of cost-effectiveness in screening, diagnosis, and treatment of colorectal cancer
by Mónica A. Velásquez & Vivienne C. Bachelet
- 1-15 Health insurance coverages and demand for modern contraceptive choices among reproductive-age women in Thailand
by Nattanon Phonkacha & Piriya Pholphirul
- 1-15 Technical efficiency of sub-district level hospitals in Bangladesh: a comparative frontier analysis
by Md. Zahid Hasan & Edward JD Webb & Silviya Nikolova & Khadija Islam Tisha & Zahidul Quayyum & Tim Ensor
- 1-15 Analysis and interpretation of the heterogeneity of community-based health insurance attributes and preferences in Senegal: evidence from a discrete choice experiment
by Oumar Sagna
- 1-16 The economic burden of mental health deterioration on Australian households: a longitudinal analysis of out-of-pocket healthcare expenditures
by Md Ehsanul Haque Tamal & Kamrul Hassan & Dominic Gasbarro & Khurshid Alam
- 1-16 Securing Somalia’s health: leveraging sin tax revenues to drive universal health coverage and financial protection for lifesaving care in Somalia’s health system-scoping review
by Saadaq Adan Hussein & Marian Muse Osman & Yakub Burhan Abdullahi & Mohamed Mohamoud Hassan & Abdihakim Ibrahim Ahmed & Naima Ibrahim Ahmed & Yahye Sheikh Abdulle Hassan & Abdirahman Aden Hussein & Rage Adem & Abdirahman Moallim Ibrahim & Yusuf Hared Abdi & Ayan Nur Ali & Abdinur Hussein Mohamed & Abdullahi Ahmed Tahlil & Sharmake Gaiye Bashir & Mohamed Sharif Abdi & Khadar Hussein Mohamud & Abdihakim Mohamed Hassan & Mohamed Ahmed Ali & Mohamed Farah Yusuf & Abdinur Adan Hussein & Mohamed Sheikh Hassan & Walid Abdulkadir Osman
- 1-16 Pay attention to your social capital! It determines your health: an analysis for the elderly in Europe
by Javier Lera & David Cantarero-Prieto & Sara Pinillos-Franco
- 1-16 Socioeconomic barriers to healthcare cost-sharing in the Czech Republic: limited awareness and resistance
by Jan Hodač & Drahomíra Holmannová & Eva Čermáková & Michaela Tauchmanová Spoustová & Roman Prymula & Lenka Hodačová
- 1-16 Behavioral responses of healthcare providers to prospective payment systems: a systematic review using the WHO framework (2000–2024)
by Anahita Behzadi & Zohreh Bagherinezhad & Maliheh Ghobadi
- 1-16 The economics of decision-making in dementia care and related life-limiting illness: a narrative review
by Ana Maksimovic & Simona Grassi & Clare Ellis-Smith & Peter May
- 1-17 Catastrophic and impoverishing health expenditures in fragmented public health systems: lessons from Mexico, 2000–2022
by Diego Cerecero-García & Octavio Gómez-Dantés & Thomas Hone & Carlos Pineda-Antúnez & Alejandro Mohar-Betancourt & Laura Flamand & Edson Serván-Mori
- 1-17 A systematic review of economic evaluations of community-based healthcare interventions for neurodisability management
by Áine J. Gorman & Ann Kirby & Peter Cleary & Mari O’Connor & Aileen Murphy
- 1-17 Does long-term care insurance promote assistive device utilization? Evidence from pilot regions in China
by Xiaoting Liu & Jinjing Fu & Wenxuan Zhu & Hao Lyu & Shimin Li & Yanru Wang
- 1-17 Micro-costing of genetic and genomic testing in oncology: a systematic review of laboratory resources and costs
by Sook Pin Goh & Jue Ern Chan & Siew Chin Ong
- 1-17 Health shocks and labour market outcomes: evidence from The Irish Longitudinal Study on Ageing (TILDA)
by Likun Mao & Charles Normand
- 1-18 Cost-effectiveness analysis of intensive and emerging rehabilitation therapies in children with cerebral palsy: an observational cohort study using real-world evidence and microsimulation modelling
by Diana Marcela Nova-Díaz & Sergio Aguilera-Albesa & Eduardo Sánchez-Iriso
- 1-18 Understanding recent dynamics: prosperity and longevity in Ghana
by Ussif Abdul-Aziz Sirin & Reiner Anafo & Edward Ebo Onumah & Jamal Mohammed & Ramatu Ussif
- 1-18 Can the remuneration scheme of general practitioners affect their antibiotic prescription behaviour?
by Yana V. Zykova & Eivor H. Hoff & Kristian B. Kraft & Arnstein Mykletun & Kristian A. Østby
- 1-19 Financial burden of noncommunicable diseases on households in Bangladesh: a quasi-experimental analysis using national survey data
by Taslima Rahman & Dominic Gasbarro & Khurshid Alam
- 1-19 Protecting healthcare workers? Effects of a multilevel intervention targeting emotional demands
by Louise Schubert Paaske & Nicolai Simonsen Damslund & Ida Elisabeth Huitfeldt Madsen & Sofie Østergaard Jaspers & Line Planck Kongstad
- 1-21 Provider behavior from FFS to DRGs payment: experimental evidence from real physicians
by Yefeng Chen & Weizheng Zhao & Ying Liu & Jun Luo
- 1-21 The economic impact of retinal diseases for which gene therapy is emerging: a systematic literature review
by Claire Willmington & Ann Kirby & Aileen Murphy
- 1-21 Estimating the causal effect of cardiometabolic conditions on socioeconomic and healthcare outcomes: a scoping review of Mendelian randomization studies
by Sara Pedron & Xiao Tan & Juliane Maushagen & Anna-Janina Stephan & Jacob Burns & Eleanor Sanderson & Kaitlin Wade & Michael Laxy
- 1-22 Harnessing oil revenues for sustainable development: evaluating Brazil’s “royalties’ law” and its impact on healthcare
by Rômulo E. de A. Rodrigues & Wallace P. S. de Farias Souza & Jevuks Matheus de Araújo
- 1-23 Does price disclosure promote competition in private MRI markets? A difference-in-differences analysis
by Riina Hiltunen
- 1-23 Environmental regulation and industrial restructuring: choices of health industry enterprises in China
by Yao Yao & Yujie Cui & Gordon Liu
- 1-23 Health economic evaluation of health promotion and disease prevention in Germany: a scoping review
by Eva Juliane Beer & Michaela Kirschneck & Michaela Coenen & Rosa Maria Sija Visscher
- 1-26 Real-time healthcare staffing optimization using fuzzy logic and genetic algorithm
by Balveer Saini & Dinesh Kumar Saini
- 1-28 Cost effectiveness of comprehensive geriatric assessment: a systematic review
by Alberto Pilotto & Francesco Saverio Ragusa & Nicola Veronese & Carlo Custodero & Pascal Roberto Titone & Giusy Vassallo & Emanuele Seminerio & Wanda Morganti & Alessandro Botrugno & Benedetta Margilio & Mario Barbagallo & Romina Custureri & Mickaël Hiligsmann
- 1-30 Selecting risk adjusters with penalized regression and expert judgment: evidence from Colombia
by Camilo Arias
December 2025, Volume 15, Issue 1
- 1-1 Correction: The effect of basic public health service equalization on settlement intention of migrant workers in China: the mediating effect model based on subjective feelings
by Pei Liu & Zhiping Long & Xuemeng Ding
- 1-3 Matters arising: cost-utility and cost-effectiveness analysis of disease-modifying drugs of relapsing–remitting multiple sclerosis: a systematic review
by Carlo Lazzaro & Roberto Bergamaschi & Mauro Zaffaroni & Rocco Totaro & Damiano Paolicelli
- 1-4 Impacts and lessons learned from coronavirus-19 pandemic in the United States: preparing for future public health emergencies
by Obert Xu
- 1-4 Lorenz curves of urban and rural health care expenditure in Colombia: analysis of a cohort of 4.6 million patients
by Oscar Espinosa & Giancarlo Buitrago & Valeria Bejarano & Ramon Castaño
- 1-5 Health insurance premium in Colombia for 2025: a strictly political-ideological decision without technical-scientific arguments?
by Oscar Espinosa & Paul Rodríguez-Lesmes & Sergio Prada & Mery Bolívar & Juan Diego Mejía-Becerra & Andrés I. Vecino-Ortíz
- 1-6 Sustainable AI in medicine: navigating innovation, challenges, and environmental impact
by Elena Bignami & Luigino Jalale Darhour & Valentina Bellini
- 1-8 Sustainability of national health insurance scheme in Ghana: what is the effect of enrolment on retention and what are the constraints?
by Nicholas Kwame Essah
- 1-8 Effects of emergency department length of stay on inpatient utilization and mortality
by Kai-Jie Ma & Yi-Chen Hsu & Wei-Wen Pan & Ming-Hsien Chou & Wei‑Sheng Chung & Jong-Yi Wang
- 1-8 What does it drive the relationship between cardiovascular disease mortality and economic development? New evidence from Spain
by Carla Blázquez-Fernández & David Cantarero-Prieto
- 1-8 Governance and public health expenditure in Côte d'Ivoire: examination of the dynamic relationship
by Alliou Salihini Diarrassouba & Foungnigué Noé Coulibaly & Anzoumana Comoé
- 1-9 Economic burden of end stage renal disease: a case study in southern Iran
by Habib Omranikhoo & Saeed Shabani & Atefeh Esfandiari & Hedayat Salari & Mehdi Rezaee
- 1-9 Budgetary impact of increasing use of peritoneal dialysis over haemodialysis in Spain
by Gemma Barbado & Carla Garí & Asís Ariznavarreta & Neus Vidal-Vilar & Carlos Alvarez
- 1-9 Increasing patient access to faecal microbiota transplantation with remote delivery: a cost analysis of outpatient versus home-based treatment
by Renée Hangaard Olesen & Emma Bendix Larsen & Tone Rubak & Simon Mark Dahl Baunwall & Sara Ellegaard Paaske & Merete Gregersen & Christian Erikstrup & Katrin Olsen & Jens Frederik Dahlerup & Thea Kirkegaard Kjaer & Camilla Birch Krogh & Lars Holger Ehlers & Christian Lodberg Hvas
- 1-9 Horizon scanning and drug expenditure for rare diseases: three-year predictive model in Italy 2025–2027
by Andrea Marcellusi & Daniela Cazzato & Giulio Guarnotta & Andrea Aiello & Marzia Bonfanti & Rossella Bitonti & Melissa Guardigni & Chiara Lucchetti & Fulvio Luccini & Pier Luigi Canonico & Claudio Jommi
- 1-9 A retrospective study “myo-inositol is a cost-saving strategy for controlled ovarian stimulation in non-polycystic ovary syndrome art patients.”
by Cesare Aragona & Michele Russo & Samuel H. Myers & Maria Salomé Bezerra Espinola & Gabriele Bilotta & Vittorio Unfer
- 1-9 Relationship between economic recessions and health inequity: analysis of the gap in life expectancy at birth between Mexican States
by Juan Pablo Gutiérrez & Karina Mendoza & Armando Sánchez-Vargas & Stefano M. Bertozzi
- 1-9 Two-year retrospective review of costs associated with COVID-19 case management in Regina, Saskatchewan
by Olanrewaju Medu & Molly Trecker & Tania Diener & Maurice Hennink & Doug Coyle & Jessica Minion & Cara Benz & Amanda Lang & Maureen Anderson & Thomas Stewart & Tandi Steenkamp
- 1-9 Confidence in China’s healthcare system: a focus on lower-middle class
by Yifan Jiang & Bin Peng & Dandan Jin & Xinxin Peng & Jinghua Zhang
- 1-10 Framing financial incentives to promote hypertension care among rural primary doctors in Shandong Province, China: study protocol of a randomized field trial
by Yue Zhong & Pengyang Fan & Jialong Tan & Elizabeth Maitland & Stephen Nicholas & Yiwei Qiao & Dejian Kou & Zehua Meng & Jian Wang
- 1-10 Medicare Advantage penetration and the financial distress of rural hospitals
by Guido Cataife & Siying Liu
- 1-10 Economic burden and cost drivers of generalized pustular psoriasis: a systematic review
by Xin Qian Seah & Mustapha Mohammed & Siew Chin Ong
- 1-10 The importance of political and religious affiliation in explaining county-level COVID-19 Vaccine Hesitancy
by Declan R. Carroll & Stephen J. Conroy & Adriana Vamosiu
- 1-10 The impacts of the diagnosis-related group payment reform on hospitalization-related medical expenses: evidence from China
by Lele Li & Wei Yang & Xiaozhe Tang & Siyu Zeng & Xiaofei Liu & Siping Dong
- 1-10 Cost effectiveness of imaging strategies in the emergency department for the diagnostic workup of community-acquired pneumonia: a real-life retrospective study
by Sabrina Kepka & Kevin Zarca & Mickaël Ohana & Louise Hoffbeck & Charlène Heimann & Pierrick Le Borgne & François Severac & Joris Muller & Erik-André Sauleau & Pascal Bilbault & Isabelle Durand Zaleski
- 1-10 Difference in time and risk preferences: physicians and general population across genders
by Shingo Kasahara & Hirotaka Kato & Rei Goto
- 1-10 Household health-seeking behaviour and response to Informal payment: does economic status matter?
by Chukwudi Nwokolo & Obinna Onwujekwe & Martin McKee & Iheomimichineke Ojiakor & Blake Angell & Dina Balabanova
- 1-10 What can we learn about the impact of cancelled planned operations on waiting times? A case study using the 2017/18 winter flu postponement policy in England
by Maria Ana Matias & Rita Santos & Nils Gutacker & Anne Mason & Nigel Rice
- 1-10 AI integration in energy management: enhancing efficiency in Italian hospitals
by Paolo Pariso & Michele Picariello & Alfonso Marino
- 1-10 Cost-effectiveness of the addition of sintilimab as a first-line therapy for locally advanced or metastatic oesophageal squamous cell carcinoma: a Chinese healthcare system perspective
by Cuicui Yu & Yingqi Wu & Yadi Geng & Hui Yan & Pengli Zhu & Peng Ji & Fei Wu & Lijuan Ning & Yubin Feng & Aizong Shen
- 1-10 The financial repercussions of rheumatoid arthritis and determinants of catastrophic healthcare expenditure: insights from the Karnataka chapter of the Indian rheumatology association
by Vineeta Shobha & Shweta Singhai & Vikram Haridas & Shaleni V. & Subramanian R. & Mahabaleshwar Mamadapur & Ashwini Kamath & Arjun M.N. & Pramod Chebbi & Jacob Mathews Vahaneyil & Silas Vinay V.R. & Abhishek Patil & Benzeeta Pinto & Prakruthi J. & Yathish G.C. & Sachin R. Jeevanagi & Sahana Baliga & Harshini A.S. & Vijay K. Rao & Veena Ramachandran & Matam Sri Anusha & Sumithra Selvam & Chandrashekara S. & K.M. Mahendranath
- 1-10 Economic evaluation of inpatient medication reconciliation with a subtraction strategy
by Nontakorn Khomsanoi & Theetad Chombandit & Jurinporn Wiwatmanaskul & Chatchai Kreepala
- 1-10 Cost-minimization analysis of postoperative antibiotic use in high horseshoe anal fistula: evidence from a randomized controlled trial in China
by Xue Li & Yicheng Cheng & Pengyi Xu & Zijian Wei & Chen Li & CongCong Zhi & Xin Li & Ye Yuan & Lihua Zheng
- 1-10 Cost-effectiveness analysis of robotic-arm assisted total knee arthroplasty (TKA) versus conventional TKA in Iranian population
by Zahra Goudazi & Mojtaba Jafari & Abdollah Kiyaei & Ramin Ravangard & Seyed Ali Hashemi & Khosro Keshavarz
- 1-10 Determinants of the perceived financial threat of COVID-19 and implications for household economic stability: an application of the partial proportional odds model
by Maru Zewdu Kassie & Seyifemickael Amare Yilema & Alebachew Taye Belay & Najmeh Nakhaei Rad & Ding-Geng Chen
- 1-11 Determinants of medical borrowing and associated inequalities in the Kingdom of Saudi Arabia: evidence from the Global Findex survey
by Mohammed Khaled Al-Hanawi
- 1-11 Primary endocrine therapy versus surgery plus endocrine therapy for early-stage breast cancer in older women without frailty: a cost-effectiveness and value of implementation analysis
by Yubo Wang & Li-Chia Chen & Kwok-Leung Cheung & Douglas Steinke & Sean P. Gavan
- 1-11 Screening for postpartum depression at well child visits: evaluating the impact of Michigan’s statewide initiative
by Janet Currie & Anna Malinovskaya
- 1-11 Public perceptions of high-cost cancer drugs and the implications for reimbursement decisions
by Youran Noh & Kyung-Bok Son
- 1-11 Health economic evaluations of fecal microbiota transplantation for non-clostridioides difficile related diseases: a systematic review
by Qiran Wei & Yingcheng Wang & Mingjun Rui & Joyce H.S. You
- 1-11 Impacts of the diagnosis-intervention packet reform on costs and healthcare resource utilization: evidence from Guangzhou, China
by Bingxue Fang & Yawen Jiang
- 1-11 Applications of artificial intelligence and the challenges in health technology assessment: a scoping review and framework with a focus on economic dimensions
by Maryam Ramezani & Ahad Bakhtiari & Rajabali Daroudi & Mohammadreza Mobinizadeh & Ali Akbar Fazaeli & Alireza Olyaeemanesh & Hamid R. Rabiee & Maryam Ramezani & Hakimeh Mostafavi & Saharnaz Sazgarnejad & Sanaz Bordbar & Amirhossein Takian
- 1-11 Impact of outpatient palliative care on healthcare costs in Germany – an analysis of cancer and non-cancer patients based on health insurance data
by Melissa Hemmerling & Sabrina Schütte & Sveja Eberhard & Katharina Baal & Stephanie Stiel & Jona Theodor Stahmeyer
- 1-11 Modeling in R: a practical application using a cost-effectiveness analysis
by Jean Martial Kouame & Carole Siani & Christian Kouakou & Soualio Gnanou & Simon LaRue & Jason Robert Guertin
- 1-11 Catastrophic health expenditures and food insecurity among older cancer survivors in the United States
by Tae-Young Pak
- 1-11 Exploration of health care utilization, social care utilization and costs for individuals discharged from inpatient geriatric care in Sweden - a registry data study
by Carl Willers & Rikard Lindqvist & Stefan Fors & Amelie Lindh Mazya & Gunnar H Nilsson & Anne-Marie Boström & Elisabeth Rydwik
- 1-11 Risky behaviours and injuries amongst Catalan children with ADHD: does pharmacological treatment improve outcomes?
by Toni Mora & Rowena Jacobs & Jordi Cid & David Roche
- 1-11 Is the construction of high-speed rail crowding out the market for medical care services at county? Quasi-experimental evidence from China
by Liu Yang & Zhongliang Zhou & Yawei Huang & Sha Lai & Chi Shen
- 1-11 Cost-effectiveness of antibody-drug conjugates in previously treated metastatic triple-negative breast cancer in China
by Shixian Liu & Kaixuan Wang & Ruixue Wang & Hao Chen & Ziming Wan & Lei Dou & Shunping Li
- 1-11 Estimating the direct medical cost of illness of COVID-19 hospitalisations in Kuwait: efficiency trade-offs from real-world data analysis
by Mohammad Almari & Anna Vassall & Stephen O’Neill & Zia Sadique
- 1-11 Cost-effectiveness analysis of penpulimab plus carboplatin-paclitaxel as first-line treatment for metastatic squamous non-small-cell lung cancer in China
by Luwei Wang & Jiasheng Chen & Lihui Lin & Xiaowei Huang
- 1-12 The economic benefit of implementing assisted reproductive technology within a national health system: insights from the Italian model
by Andrea Marcellusi & Matteo Scortichini & Giulio Guarnotta & Mark Connolly & Andrea Busnelli
- 1-12 Societal cost-of-illness analysis of self-injection of biologics for patients with rheumatoid arthritis in Japan using claims, surveys, and national statistics
by Kazuhiko Takahata & Eiichi Tanaka & Ryoko Sakai & Manabu Akazawa
- 1-12 Health economic evaluations of diagnostic tests for tuberculosis: a narrative review
by Cemre Arpa & Ahmed Abd El Wahed & Serap Aydin & Prakash Ghosh & Dinesh Mondal & Lydia Nakiyingi & Julius Boniface Okuni & Sophie Schneitler & Manfred Weidmann & Martin Siegel
- 1-12 Impact of China Guidelines for Pharmacoeconomic Evaluations on study quality: a systematic review of economic evaluations in China
by Shihuan Cao & Wanxian Liang & Changhao Liang & Huansen Lin & Chenxi Gao & Lujia Yang & Yuming Liu & Yusi Suo & Kexin Liu & Yunzheng Chen & Lining Zhang & Hanfei Wang & Han Wang & Xuejing Jin
- 1-12 Calculating willingness-to-pay with discrete cost and random coefficients in discrete choice experiments
by Clarence Ong & Alex R. Cook & Ker-Kan Tan & Yi Wang
- 1-12 The cost of being gluten-free: a hedonic pricing analysis of food products for celiac patients
by Laia Soler & Nicolas Borzykowski
- 1-12 How was published evidence used in model-based cost-utility analysis for lung cancer?
by Haijing Guan & Chunping Wang & Ruowei Xiao & Ting Zhou & Wei Li & Yanan Xu & Hongting Nie & Zhigang Zhao & Sheng Han & Feng Xie
- 1-12 Epidemiology and hospitalization costs of chronic kidney disease in Romania
by Ildiko Aliz Bradacs & László-István Bába & László Lorenzovici & Andreea Mihaela Precup & Szabolcs Farkas- Ráduly & Gyongyi Tar & Vasile Nastase & Lucia Georgeta Daina & Raul Bozu & Gyula Jozsef Nagy & Dimitrie Cristian Siriopol & Dorel Sandesc & Ovidiu Horea Bedreag & Florin Buicu & Gabriel Mircescu & Gener Ismail
- 1-12 Cost–benefit analysis of the quarantine policy during the outbreak of the Covid-19 virus in Iran
by Morteza Tahamipour Zarandi & Kimia Haghbandeh
- 1-13 The moral dilemma of healthcare service utilization: a perspective from the consolidation of urban and rural resident health insurance policy in China
by Hui Yuan & Jubo Han & Ruifeng Luo
- 1-13 Catastrophic and impoverishing out-of-pocket health expenditure in Ethiopia: evidence from the Ethiopia socioeconomic survey
by Yamlak Bereket Tadiwos & Meseret Molla Kassahun & Anagaw Derseh Mebratie
- 1-13 A cost-effectiveness analysis comparing single-inhaler extrafine beclomethasone/formoterol/glycopyrronium bromide against other SITTs in adult patients with uncontrolled asthma in England
by Ioanna Vlachaki & Simon Donhauser & Alessandra Madoni & Marielle Deijl & Yuvraj Sharma & Dimitrios Tzelis & Ines Guerra
- 1-13 Impact of Tobacco Use and Prevention Laws on Regional Cigarette Sales: An Analysis of Provincial Disparities and Convergence Patterns in Spain
by Aida Galiano & Josep Blasco & Juan Manuel Martín-Álvarez & Miguel Angel Arco Osuna
- 1-13 Cost-effectiveness analysis of duodenal–jejunal bypass sleeve device for people with obesity
by Qian Xu & Wei Yan & Luo Li & Bao Liu
- 1-13 Physician agency in China: evidence from physicians’ responses to financial pressure during the COVID-19 pandemic
by Qi Zhang
- 1-13 An econometric examination of vaccine hesitancy among residents and their dependents in urban Ghana
by Rexford Kweku Asiama
- 1-13 Exploring patient and provider perspectives on health insurance effectiveness in cameroon: a qualitative study
by Adanze Nge Cynthia & Bülent Kılıç
- 1-13 The bill of aging: fiscal projections of demographic changes on South Korea’s national health insurance, 2023–2042
by Younhee Kim & Kyung-sook Woo
- 1-13 Cost-effectiveness of expanding the target population of biennial screening for breast cancer from ages 50–69 to 45 and/or 74: A cohort modelling study in the Finnish setting
by Filip Siegfrids & Sirpa Heinävaara & Tytti Sarkeala & Laura Niinikoski & Juha Laine
- 1-13 Efficiency in COVID-19 inpatient care: findings from public hospitals in Iran
by Rajabali Daroudi & Behzad Raei & Reza Goudarzi & Soheila Damiri & Hossein Ranjbaran & Zahra Shahali
- 1-14 Global burden and cross-country inequalities in head and neck cancer from 1992 to 2021: results from the global burden of disease study
by Shijie Sun & Manman Lu & Shen’ao Wei & Yuwei Liang & Ziyi Zhang & Huadong Wang & Lei Si
- 1-14 Economic and demographic influences on health expenditures: robust approaches for income and aging effects
by Canser Boz & Fatma Sevinç Kurnaz
- 1-14 Behavioural insights in the underuse of cardiac resynchronisation therapy in heart failure: a pilot survey on incentive perceptions among referring cardiologists
by Joan Costa-i-Font & Georgiana Miler-Raicu & Elena Arbelo & Ruben Casado-Arroyo & Aya Sami & Eric Wei Seong Tee & Joseph Hazel & Laurent Roten & Tobias Reichlin & Haran Burri & Khaled Albouaini & Nikola Kozhuharov
- 1-14 Robot-assisted approach versus open surgery and conventional laparoscopy for radical prostatectomy for prostate cancer: a micro-costing study
by Sophie Bouvet & Sihame Chkair & Jean Pierre Daurès & Sarah Kabani & Thierry Chevallier & Eric Lechevallier & Stéphane Droupy
- 1-14 Measurement of catastrophic health expenditures in households with essential hypertension and type 2 diabetes mellitus in cold regions of China
by Haofei Li & Xiangjin Cui & Yiyin Cao & Xu Jin & Jiaxuan Shi & Lei Leng & Lijun Xu & Tiemin Zhai & Weidong Huang
- 1-14 Three decades in healthcare service efficiency evaluation: a bootstrapping Data Envelopment Analysis (DEA) of Ministry of Health Malaysia
by M Zulfakhar Zubir & Aizuddin A.N & Mohd Rizal Abdul Manaf & A Aziz Harith & M Ihsanuddin Abas & Maizatul Izyami Kayat & M Firdaus M Radi & Mas Norehan Merican & Nurcholisah Fitra & Affendi M Ali & Sharifah Ain Shameera Syed Rusli
- 1-14 Wealth, health expenditure and cancer: an econometric analysis for European countries
by Bayram Aydın & Emine İlkin Aydın
- 1-14 Understanding women’s preferences for long-acting reversible contraceptives in Gondar, Ethiopia: a discrete choice experiment
by Ousman Ambaw & Amare Minyhun & Tsegaw Amare Baykeda & Haimanot Wubale Tewabe & Endalew Minwuye Andargie & Yihalem Abebe Belay & Dessie Tarko Ambaw & Lei Si
- 1-15 Payment compliance of informal sector workers in Indonesia National Health Insurance: a study on ability and willingness to pay
by Muhammad Syamsu Hidayat & Yudistira Hendra Permana & Diah Ayu Puspandari & Dedy Revelino Siregar & Hermawati Setyaningsih & Vini Aristianti & Wan Aisyah Baros & Zafria Atsna & Findri Fadlika & Azizah Boenjamin
- 1-15 Renal denervation for hypertension: cross-country cost-effectiveness insights from mainland China, Japan, and Thailand
by Dai Lian & Yue Suo & Ruoyan Gai & Ning li & Yunfeng Ren & Dunming Xiao & Jiaxin Zhao & Mingdong Zhang & Shimeng Liu & Yingyao Chen
- 1-15 Economic costing methodologies for drug-resistant bacterial infections in humans in low-and middle-income countries: a systematic review
by Edward Masoambeta & Charity Mkwanda & Edna Ibrahim & Kenneth Chizani & Chikondi Chapuma & Priscilla Dzanja & Edson Mwinjiwa & Raphael Chanda & Mirfin Mpundu & Luigia Scudeller & Tomislav Kostyanev & Finola Leonard & Surbhi Malhotra-Kumar & Fiammetta Bozzani & Eric Umar & Rajab Mkakosya & Chantal Morel & Chisomo Msefula & Jobiba Chinkhumba
- 1-15 Health and economic gains from bariatric surgery in Portugal: an in-depth analysis using a Markov model
by Pedro Cardoso & Patrícia Redondo & Pedro Castro & Joana Sousa & Joana Oliveira Fagundes
- 1-15 Implementing performance-based risk-sharing agreements in non-small cell lung cancer immunotherapy: a real-world data case study
by Adéla Bártová & Filippo Rumi & João Vasco Santos & Adam Svobodník & Barbora Rihova
- 1-15 Global economic burden of diabetic related hypoglycemia: a systematic review of cost of illness studies
by Bezie Kebede & Abinet Abebe & Bezuayehu Alemayehu
- 1-15 Overuse of medical imaging and effects of payer-provider integration: quasi-experimental evidence from Finland
by Konsta Lavaste
- 1-15 Does public indebtedness matter in the effect of public health expenditure on human longevity in Sub-Saharan Africa countries? Evidence from dynamic panel threshold regression
by Jacques Boundioa
- 1-15 The impact of multidimensional poverty on antenatal care service utilisation in Malawi
by Amanda Grace Chatata & Gowokani Chijere Chirwa
- 1-15 Valuation of informal care for the old-aged with disabilities in China—a discrete choice experiment approach
by Zhan Zhao & Shuaizhen Chen & Fengyi Sun & Wenjing Cheng & Chen Chen & Elizabeth Maitland & Stephen Nicholas & Jian Wang & Lei Si & Jialong Tan
- 1-15 Key indicators for evaluating Iran’s health insurance performance
by Alireza Olyaeemanesh & Amirhossein Takian & Mohammad Effatpanah & Mohammad Mehdi Nasehi & Zahra Shahali & Sahar Kargar & Mohammadreza Mobinizadeh & Efat Mohamadi
Printed from https://ideas.repec.org/s/spr/hecrev.html